Research News and Research

RSS

Solos Endoscopy to launch new urology product line

Solos Endoscopy, Inc. is pleased to announce that the Company is set to introduce a new product line consisting of urology surgical and diagnostic instruments.

24 Feb 2011

California researchers receive InHealth grant to evaluate device-intensive procedures

The Institute for Health Technology Studies has awarded a $263,000 grant to a research team at the University of California, Berkeley, to identify and analyze the strategies that hospital systems employ to evaluate and purchase implantable medical devices for cardiac, spinal, and orthopedic procedures.

23 Feb 2011

New research: Alzheimer's disease may be easily misdiagnosed in elder people

New research shows that Alzheimer's disease and other dementing illnesses may be easily misdiagnosed in the elderly, according to early results of a study of people in Hawaii who had their brains autopsied after death. The research is being released today and will be presented as part of a plenary session at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

23 Feb 2011

Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice

Whether on a battlefield, in a factory or at a rock concert, noise-induced hearing loss is one of the most common hazards people face. Researchers at Washington University School of Medicine in St. Louis have identified a low-dose, two-drug cocktail that reduces hearing loss in mice when given before they are exposed to loud noise. The drugs, already FDA-approved for other conditions, also treat hearing loss after noise exposure.

23 Feb 2011

Ibio acquires Orphan Drug Designation and Fabry disease therapeutic program from Kentucky

iBio, Inc. today announced it has acquired Orphan Drug Designation for plant-produced human alpha galactosidase A and related property rights from an affiliate of Kentucky Bioprocessing LLC and has initiated a program, based on its iBioLaunch platform, to develop an improved version of the enzyme for therapy of Fabry disease.

23 Feb 2011

Aestus commences ATx08-001 phase 2 trial to evaluate efficacy of novel pain therapeutic

Aestus Therapeutics, Inc., announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.

23 Feb 2011

Australia’s top scientist takes on top job

Today, the man who is known for one of Australia’s greatest medical achievements – the development of a cervical cancer vaccine – has been appointed as Chief Executive Officer of the Translational Research Institute (TRI) in Brisbane, Queensland.

23 Feb 2011

Cell phones may lead to stimulation of parts of brain - Speculation on cancer continues

There is still debate as to whether cell phones damage the brain. The cell phone industry, along with nearly all major national and international medical associations have always responded with the same answer that there is no evidence that cell phone radiation can even affect the brain, let alone cause cancer.

23 Feb 2011

Biological pathways in PTSD revealed: Study

Up to 20% of the population exposed to a horror of a war, trauma or abuse may go on to develop post-traumatic stress disorder. PTSD, as it is better known, is a debilitating psychiatric disorder marked by flashbacks and nightmares. Till date the biological basis for PTSD was unclear. But a new study offers clues about why some people rebound from horrific events while others relive them, and may lead to predictive tests and even treatments.

23 Feb 2011

Finally! A vaccine against Dengue

Scientists from Thailand have successfully produced the world’s first dengue hemorrhagic fever vaccine and will allow the private sector improve it for the effective treatment of patients. The Thailand Ministry of Science and Technology has introduced the world’s first live attenuated dengue hemorrhagic fever vaccine.

23 Feb 2011

Prevalence of bunions increases with age; More common in women

New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.

23 Feb 2011

Multi-national consortium develops new approaches to cure the flu

Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project “FLUCURE” supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses. The consortium also joined Vironova AB and Beactica AB (Sweden), Pike Pharma GmbH (Switzerland) and university-based research groups from Italy, Germany, Bulgaria, Lithuania, and the Netherlands.

23 Feb 2011

Versatile ultra-low power biomedical signal processor

At today’s International Solid-State Circuit Conference (ISSCC2011), imec, Holst Centre and NXP present a versatile ultra-low power biomedical signal processor, CoolBioTM, meeting the requirements of future wearable biomedical sensor systems. The biomedical signal processor consumes only 13pJ/cycle when running a complex ECG (electrocardiogram) algorithm at 1MHz and 0.4V operating voltage. This C-programmable chip is voltage and performance scalable supporting a frequency range of 1MHz up to 100MHz with an operating voltage from 0.4 to 1.2V.

23 Feb 2011

MassHealth call center earns Center of Excellence designation

MAXIMUS, a leading provider of government services, announced today that its Massachusetts Health Benefits Customer Service project call center has once again been recognized as a "Certified Center of Excellence" by BenchmarkPortal in collaboration with the Center for Customer-Driven Quality at Purdue Research Park.

23 Feb 2011

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

NanoViricides, Inc.announced today that Anil R. Diwan, PhD, President of the Company, gave a presentation on Friday, February 18th, that discussed the Company's anti-viral technology and more specifically, results from both in-vitro and in-vivo studies of its drug candidates against dengue virus infections that can potentially cause a fatal manifestation, viz. dengue hemorrhagic fever.

23 Feb 2011

Pharmacelsus participates in FLUCURE project to develop novel therapeutics against influenza

Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project "FLUCURE" supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses.

23 Feb 2011

Study: Mormon polygamy reduces strength of sexual selection on males by 58%

Polygamy practiced by some 19th century Mormon men had the curious effect of suppressing the overall offspring numbers of Mormon women in plural marriages, say scientists from Indiana University Bloomington and three other institutions in the March 2011 issue of Evolution and Human Behavior.

23 Feb 2011

Healthcare professionals need evidence-based education, guidance about CAM use in maternity care

Complementary and alternative medicine is increasingly popular in maternity care, but healthcare professionals need formal evidence-based education and guidance about its use, according to a review in the March issue of the Journal of Advanced Nursing.

23 Feb 2011

New analysis: Female scientists win fewer awards for research

Women scientists must confront sexism when competing for awards that recognize their research, according to a new analysis.

23 Feb 2011

Hearing aids with the latest technology through NHS

In the UK we are fortunate enough to have a free provision of hearing aids by way of the NHS. Over the last few years, the NHS has switched from analogue to digital hearing aids for the majority of patients. These hearing instruments are of a reasonable quality and are programmed to match the patients hearing loss. Fantastic! I hear you say, but there's perhaps a little more to this situation than meets the eye.

23 Feb 2011

Research News and Research

Solos Endoscopy to launch new urology product line

California researchers receive InHealth grant to evaluate device-intensive procedures

New research: Alzheimer's disease may be easily misdiagnosed in elder people

Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice

Ibio acquires Orphan Drug Designation and Fabry disease therapeutic program from Kentucky

Aestus commences ATx08-001 phase 2 trial to evaluate efficacy of novel pain therapeutic

Australia’s top scientist takes on top job

Cell phones may lead to stimulation of parts of brain - Speculation on cancer continues

Biological pathways in PTSD revealed: Study

Finally! A vaccine against Dengue

Prevalence of bunions increases with age; More common in women

Multi-national consortium develops new approaches to cure the flu

Versatile ultra-low power biomedical signal processor

MassHealth call center earns Center of Excellence designation

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

Pharmacelsus participates in FLUCURE project to develop novel therapeutics against influenza

Study: Mormon polygamy reduces strength of sexual selection on males by 58%

Healthcare professionals need evidence-based education, guidance about CAM use in maternity care

New analysis: Female scientists win fewer awards for research

Hearing aids with the latest technology through NHS

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News